z-logo
open-access-imgOpen Access
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients
Author(s) -
Yi-Chang Liu,
Ching-Ping Lee,
Tsung-Jang Yeh,
Yuh-Ching Gau,
ChiehYu Hsieh,
YaLun Ke,
Jeng-Shiun Du,
Meixia Lin,
HuiChing Wang,
ShihHao Tang,
ShihFeng Cho,
Chi-En Hsiao,
JenFu Hsu,
Samuel Yien Hsiao,
ChinMu Hsu,
Hui-Hua Hsiao
Publication year - 2020
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2020.022
Subject(s) - calreticulin , high resolution melt , essential thrombocythemia , medicine , mutation , exon , gene mutation , gastroenterology , gene , polymerase chain reaction , genetics , platelet , biology , endoplasmic reticulum
Somatic mutations of exon 9 of calreticulin gene (CALR) were diagnosis and prognosis importance found in patients with JAK2V617F-negative essential thrombocythemia (ET). We survey CALR and JAK2 mutations in our ET patients and study the relationship between mutations and clinical presentations. A total of 60 ET patients were enrolled in the study, and CALR mutations were studied by high resolution melting (HRM) methods and sequencing in JAK2V617F-negative group retrospectively. Clinical manifestations were reviewed retrospectively from chart records. Twenty-one CALR mutations showed eight types of specific melting curves detected by the HRM method and sequencing validation among 26 JAK2 V617F-negative patients. Compared with JAK2 mutations, patients with CALR mutations were younger and had a higher platelet count, lower white cell counts, and lower hemoglobin levels significantly (p<0.05). From our study, HRM methods revealed unique curve types in screening for CALR mutations screening even for complicated mutations. The mutations can be identification rapidly, and cost-effectively by HRM method than other tools. The clinical presentations of CALR mutations from JAK2 mutations showed significant differences and should be checked in ET patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here